YMAB icon

Y-mAbs Therapeutics

95 hedge funds and large institutions have $294M invested in Y-mAbs Therapeutics in 2024 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 35 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
Holders Change %
0%
% of All Funds
1.38%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
17
Increased
35
Reduced
34
Closed
16
Calls
$329K
Puts
$4K
Net Calls
+$325K
Net Calls Change
+$385K
Name Holding Trade Value Shares
Change
Shares
Change %
AIG
101
American International Group
New York
-$295K -18,132 Closed
Verition Fund Management
102
Verition Fund Management
Connecticut
-$270K -16,588 Closed
HF
103
HRT Financial
New York
-$263K -16,216 Closed
Principal Financial Group
104
Principal Financial Group
Iowa
-$223K -13,729 Closed
SG Americas Securities
105
SG Americas Securities
New York
-$195K -11,963 Closed
PAS
106
Point72 Asia (Singapore)
Singapore
-$97.9K -6,019 Closed
QT
107
Quantbot Technologies
New York
-$73.7K -4,532 Closed
ACM
108
Aquatic Capital Management
Illinois
-$53.7K -3,300 Closed
MLICM
109
Metropolitan Life Insurance Company (MetLife)
New York
-$33.4K -2,055 Closed
TAM
110
Tucker Asset Management
Colorado
-$19.5K -1,200 Closed
AWM
111
Avior Wealth Management
Nebraska
-$130 -8 Closed